Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression have?
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression has 59 citations in the OpenAlex counts ScholarIQ stores.
When was Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression published?
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression has 2022 year in the ScholarIQ index.
What is the open-access status of Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression?
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression has bronze oa status in the ScholarIQ index.
What is the DOI of Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression?
The DOI for Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression is on the source record.
What is the PMID of Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression?
The PMID for Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression is on the source record.
What is the OpenAlex record for Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression?
The OpenAlex for Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression is on the source record.